Dis-Chem Pharmacies (JSE:DCP) Research & Development: R0 Mil (TTM As of Feb. 2026)


JSE:DCP Dis-Chem Pharmacies Ltd JSE:DCP
88 GF Score
Price R33.49
GF Value R38.03
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Dis-Chem Pharmacies Research & Development?

Dis-Chem Pharmacies JSE:DCP +1.82% 88 Research & Development is R0 Mil as of Feb. 2026. GuruFocus rates JSE:DCP with a GF Score™ of 88/100 and a GF Value™ of R38.03 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Dis-Chem Pharmacies's Research & Development for the six months ended in Feb. 2026 was R0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Feb. 2026 was R0 Mil.

Dis-Chem Pharmacies  (JSE:DCP) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Dis-Chem Pharmacies Research & Development Related Terms

Dis-Chem Pharmacies Research & Development Historical Data

* Premium members only.

The historical data trend for Dis-Chem Pharmacies's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dis-Chem Pharmacies Research & Development Chart

Dis-Chem Pharmacies Annual Data
Trend Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25 Feb26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Dis-Chem Pharmacies Semi-Annual Data
Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23 Feb24 Aug24 Feb25 Aug25 Feb26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
JSE:DCP
88GF Score
Dis-Chem Pharmacies Ltd JSE:DCP
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dis-Chem Pharmacies Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Feb. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was R0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of R0 Mil mean?
Dis-Chem Pharmacies (JSE:DCP) has a Research & Development of R0 Mil as of Feb. 2026. Research and development expense is the total cost for research and development activities. View historical data on Dis-Chem Pharmacies and its competitors.
Is Dis-Chem Pharmacies' Research & Development too high?
Dis-Chem Pharmacies' current Research & Development is R0 Mil. Overall, Dis-Chem Pharmacies has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dis-Chem Pharmacies' Research & Development compare to competitors?
Dis-Chem Pharmacies' Research & Development of R0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Dis-Chem Pharmacies and its competitors. Dis-Chem Pharmacies's current Research & Development is R0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dis-Chem Pharmacies stock overvalued right now?
Based on GuruFocus' analysis, Dis-Chem Pharmacies (JSE:DCP) is currently considered Modestly Undervalued. The stock's GF Value™ is R38.03, compared to a current price of R33.49 — trading 11.9% below its estimated fair value. The current Research & Development is R0 Mil. Dis-Chem Pharmacies' overall GF Score™ is 88/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Dis-Chem Pharmacies (JSE:DCP), the current Research & Development is R0 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dis-Chem Pharmacies (JSE:DCP) Overvalued in 2026?

Based on GuruFocus' analysis, Dis-Chem Pharmacies stock appears to be undervalued. The current stock price of R33.49 is trading 11.9% below its estimated GF Value™ of R38.03. GuruFocus considers Dis-Chem Pharmacies to be Modestly Undervalued.

Key valuation signals for JSE:DCP:

  • Research & Development: R0 Mil
  • GF Value™: R38.03 vs. price of R33.49 (11.9% below fair value)
  • GF Score™: 88/100 with 5 warning signs

No single metric tells the full story. See the JSE:DCP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dis-Chem Pharmacies Business Description

Address 23 Stag Road, Glen Austin, Midrand, Johannesburg, GT, ZAF, 1685
Dis-Chem Pharmacies Ltd is a pharmaceutical company based in South Africa. Its product portfolio includes personal care products, beauty products, healthcare and nutrition products, and dispensary and baby care products. The operating segments of the group are Retail and Wholesale. It derives maximum revenue from the Retail segment, which includes company stores, retailers of pharmaceuticals and a variety of health and beauty products, as well as pharma-logistic services and oncology and retailers of pharmaceutical products. The Wholesale segment consists of the CJ wholesale and company distribution businesses, wholesalers of pharmaceuticals, and a variety of health and beauty products. Geographically, the group carries out its business operations principally in South Africa.
88GF Score

Get the complete analysis for JSE:DCP

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R33.49
Price
R38.03
GF Value